Compare CVS Health Corp (CVS) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Global X NASDAQ 100 Covered Call ETF — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while Global X NASDAQ 100 Covered Call ETF trades at $18.69 (market cap $8.49B). The key difference: CVS Health Corp is far larger — about 13.2× Global X NASDAQ 100 Covered Call ETF's market cap, and CVS Health Corp pays a 3.03% dividend while Global X NASDAQ 100 Covered Call ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Global X NASDAQ 100 Covered Call ETF for 50 Days on average.
| CVS | QYLD | |
|---|---|---|
Market Cap | $112.29B | $8.49B |
Volume | 7,763,676 | 2,913,938 |
Sector | Health | Income / Options Overlay |
52-Week High | $110.60 | $18.68 |
52-Week Low | $70.08 | $16.70 |
Typical Hold Time | 83 Days | 50 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
QYLD trades at $18.68 with no recent price movement, maintaining a stable position amidst mixed technical signals. The ETF shows a bullish moving average trend but bearish oscillators, with RSI indicating potential overbought conditions. Recent dividend distributions of $0.18 per share demonstrate consistent income generation, though news coverage highlights concerns about long-term capital erosion and tax implications of the covered call strategy.
The outlook for QYLD remains income-focused with limited growth potential. While the 12% yield provides attractive monthly cash flow, the strategy caps upside participation in Nasdaq rallies. Key risks include declining option premiums, distribution sustainability concerns, and ordinary income tax treatment that may surprise investors expecting return-of-capital benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
